94 related articles for article (PubMed ID: 6546456)
1. Inhibition of thromboxane biosynthesis in serum: limitations of the measurement of immunoreactive 6-keto-PGF1 alpha.
Pedersen AK; Watson ML; FitzGerald GA
Thromb Res; 1984 Jan; 33(1):99-103. PubMed ID: 6546456
[No Abstract] [Full Text] [Related]
2. Comparison of radioimmunoassay and high-resolution gas chromatography mass spectrometry for the quantitative determination of serum thromboxane B2 and 6-keto-PGF1 alpha after pharmacological blockade of thromboxane synthetase.
Chiabrando C; Castagnoli MN; Noseda A; Fanelli R; Rajtar G; Cerletti C; de Gaetano G
Prostaglandins Leukot Med; 1984 Oct; 16(1):79-88. PubMed ID: 6440153
[TBL] [Abstract][Full Text] [Related]
3. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
[TBL] [Abstract][Full Text] [Related]
4. Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry.
Chiabrando C; Pinciroli V; Campoleoni A; Benigni A; Piccinelli A; Fanelli R
J Chromatogr; 1989 Oct; 495():1-11. PubMed ID: 2613794
[TBL] [Abstract][Full Text] [Related]
5. In vivo redirection of prostaglandin endoperoxides into 6-keto PGF1 alpha formation by thromboxane synthetase inhibitors in the rat.
Maguire ED; Wallis RB
Thromb Res; 1983 Oct; 32(1):15-27. PubMed ID: 6689221
[TBL] [Abstract][Full Text] [Related]
6. A comparison of human pulmonary arterial and venous prostacyclin and thromboxane synthesis--effect of a thromboxane synthase inhibitor.
Carter AJ; Bevan JA; Hanley SP; Morgan WE; Turner DR
Thromb Haemost; 1984 Apr; 51(2):257-60. PubMed ID: 6377567
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane synthase inhibition: "endoperoxide shunt phenomenon" does not occur in healthy humans in vivo.
Henriksson P; Rasmanis G; Edhag O; Vesterqvist O; Gréen K
Prostaglandins; 1990 Jan; 39(1):99-107. PubMed ID: 2106716
[TBL] [Abstract][Full Text] [Related]
8. Is immunoreactive 6-keto-PGF1 alpha measured in serum after treatment with thromboxane-synthetase inhibitors an index of prostacyclin synthesis?
Cerletti C; Chiabrando C; Fanelli R; de Gaetano G
Lancet; 1984 Apr; 1(8383):967-8. PubMed ID: 6143907
[No Abstract] [Full Text] [Related]
9. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
[TBL] [Abstract][Full Text] [Related]
10. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H
Stroke; 1985; 16(2):241-4. PubMed ID: 3883580
[TBL] [Abstract][Full Text] [Related]
11. The influence of selective thromboxane synthetase inhibition with a novel imidazole derivative, UK-38,485, on prostanoid formation in man.
Fischer S; Struppler M; Böhlig B; Bernutz C; Wober W; Weber PC
Circulation; 1983 Oct; 68(4):821-6. PubMed ID: 6352080
[No Abstract] [Full Text] [Related]
12. Do prostacyclin and thromboxane play a role in endotoxic shock?
Webb PJ; Westwick J; Scully MF; Zahavi J; Kakkar VV
Br J Surg; 1981 Oct; 68(10):720-4. PubMed ID: 7025959
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of thromboxane formation prevents endotoxin-induced renal fibrin deposition in jaundiced rats.
Westwick J; Fletcher MS; Kakkar VV
Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():83-91. PubMed ID: 6221642
[No Abstract] [Full Text] [Related]
14. Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor.
Chiabrando C; Broggini M; Castelli MG; Cozzi E; Castagnoli MN; Donelli MG; Garattini S; Giavazzi R; Fanelli R
Cancer Res; 1987 Feb; 47(4):988-91. PubMed ID: 3100032
[TBL] [Abstract][Full Text] [Related]
15. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
Hardee MM; Moore JN; Hardee GE
Res Vet Sci; 1986 Mar; 40(2):152-6. PubMed ID: 3517992
[TBL] [Abstract][Full Text] [Related]
16. Determination of 6-keto-PGF1 alpha, 2,3-dinor-6-keto-PGF1 alpha, thromboxane B2, 2,3-dinor-thromboxane B2, PGE2, PGD2 and PGF2 alpha in human urine by gas chromatography-negative ion chemical ionization mass spectrometry.
Weber C; Höller M; Beetens J; De Clerck F; Tegtmeier F
J Chromatogr; 1991 Jan; 562(1-2):599-611. PubMed ID: 2026723
[TBL] [Abstract][Full Text] [Related]
17. Effects of a selective inhibitor of thromboxane synthetase (OKY-1581) in humans.
Ito T; Ogawa K; Sakai K; Watanabe J; Satake T; Kayama N; Hiraku S; Naito J
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():245-51. PubMed ID: 6221531
[No Abstract] [Full Text] [Related]
18. Enzyme immunoassay of thromboxane B2 and 6-keto-prostaglandin F1 alpha as a substitute for radioimmunoassay.
Yamamoto S; Hayashi Y; Yano T; Ueda N; Kawamura S; Ogushi F; Nakamura K
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():181-4. PubMed ID: 6221523
[No Abstract] [Full Text] [Related]
19. In vivo measurement of thromboxane B2 and 6-keto-prostaglandin F1 alpha in humans in response to a standardized vascular injury and the influence of aspirin.
Gerrard JM; Taback S; Singhroy S; Docherty JC; Kostolansky I; McNicol A; Kobrinsky NL; McKenzie JK; Rowe R
Circulation; 1989 Jan; 79(1):29-38. PubMed ID: 2910545
[TBL] [Abstract][Full Text] [Related]
20. Prostanoid synthesis by aortic rings in human blood: selective increase of prostacyclin mediated by a serum factor.
Ritter JM
Br J Pharmacol; 1984 Oct; 83(2):409-18. PubMed ID: 6386089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]